Evidence map›Paper›PMID 24511335›Full record

ArticleThe open toxinology journal2010

F A Uzal, J E Vidal, B A McClane, A A Gurjar

Open access · greenAbstract read
In one paragraph

Article in The open toxinology journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 146 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Evaluation ofFrontiers in veterinary science · 2025
    Article
  10. Article
  11. Unveiling the pathogenic mechanisms ofEmerging microbes & infections · 2024
    Review
  12. Article
  13. Article
  14. Review
  15. Antibiotics (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Article
  18. Isolation of a VirulentCurrent issues in molecular biology · 2024
    Article
  19. Review
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

F A UzalCalifornia Animal Health and Food Safety Laboratory System, San Bernardino Branch, School of Veterinary Medicine, University of California, Davis, San Bernardino, CA 92408, USA.
J E VidalDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
B A McClaneDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA ; Department of Molecular Virology and Microbiology Graduate Program, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
A A GurjarDepartment of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
University of Pittsburgh · USCalifornia State University, San Bernardino · US

Funding

Clostridium perfringens Type B-D Virulence PlasmidsR01AI056177 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MC CLANE, BRUCE A, ROOD, JULIAN · 2003 to 2013
$3.8M
NIAID NIH HHS R01 AI056177
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlphabetaClostridium perfringensCPB2CPEepsiloniotatoxins

Identifiers

PMID24511335
PMCPMC3917546
OpenAlexW2025397035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.